Solvent effects in permeation assessed in vivo by skin surface biopsy

BMC Dermatology

Volumn 3, Issue , 2003, Pages

  Rosado, Catarina ^a,b   Rodrigues, Luis Monteiro ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSIDADE LUSÓFONA DE HUMANIDADES E TECNOLOGIAS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; MACROGOL 400; METHYLENE BLUE; MYRISTIC ACID ISOPROPYL ESTER; OCTANOL; OIL SCARLET; OLEIC ACID; PROPYLENE GLYCOL; SOLVENT;

ADULT; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; REFLECTOMETRY; SKIN BIOPSY; SKIN PENETRATION; SKIN SURFACE; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ADULT; BIOPSY; FEMALE; HUMANS; MALE; METHYLENE BLUE; PERMEABILITY; PHARMACEUTICAL VEHICLES; SKIN; SKIN ABSORPTION; SOLVENTS;

EID: 2442667787     PISSN: 14715945     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-5945-3-5     Document Type: Article

References (33)

1. Chien YW: In Novel drug delivery systems: Revised and expanded Edited by: Chien YW. New York: Marcel Dekker; 1992:301-380.
2. Guy RH, Hadgraft J: Transdermal drug delivery: The ground rules are emerging. Pharm Int 1985, 6:112-116.
3. Guy RH: Current status and future prospects of transdermal drug delivery. Pharm Res 1996, 13:1765-1769.
4. Weaver JC, Chizmadzhev YA: Theory of electroporation: a review. Bioelectrochemistry and Bioenergetics 1996, 41:135-160.
5. McElnay JC, Benson HAE, Hadgraft J, Murphy M: The use of ultrasound in skin penetration enhancement. In Pharmaceutical Skin Penetration Enhancement Edited by: Walters K, Hadgraft J. New York: Marcel Dekker; 1993:293-309.
6. Mitragori S, Blankschtein D, Langer R: Ultrasound mediated transdermal protein delivery. Science 1995, 269:850-853.
7. Benson HAE, McElnay JC, Harland R, Hadgraft J: Influence of ultrasound on the percutaneous absorption of nicotinate esters. Pharm Res 1991, 8:204-209.
8. Higuchi T: Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 1960, 11:85-97.
9. Raghavan SL, Trividic A, Davis AF, Hadgraft J: Effects of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm 2000, 193:231-237.
10. Choi AHC, Basu M, Era MN, McNeal MM, Ward RL: Particle bombarded-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology 1998, 250:230-240.
11. Henry S, McAllister DV, Allen MG, Prausnitz MR: Microfabricated microneedles: A novel appoach to transdermal drug delivery. J Pharm Sci 1998, 87:922-925.
12. DeNoble LJ, Knutson K, Kurihara-Bergstrom T: Enhanced skin permeability by ethanol: Mechanistic studies of human stratum corneum measured by DSC and FTIR. Pharm Res 1987, 4:59s.
13. Embery G, Dugard PH: The isolation of dimethyl sulfoxide soluble components from human epidermal preparations: A possible mechanism of action of dimethyl sulfoxide in affecting percutaneous migration phenomena. J Invest Dermatol 1971, 57:308-311.
14. Abraham W: Surfactant effects on skin barrier. In Surfactants in Cosmetics Edited by: Rieger MM, Rhein LD. New York: Marcel Dekker; 1997:473-487.
15. Bennet SL, Barry BW: Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol 1987, 39:536-546.
16. Hadgraft J: Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999, 184:1-6.
17. Hadgraft J, Williams DG, Allan G: Azone: Mechanisms of action and clinical effect. In Pharmaceutical Skin Penetration Enhancement Edited by: Walters K, Hadgraft J. New York: Marcel Dekker; 1993:175-198.
18. Hadgraft J, Peck J, Williams DG, Pugh WJ, Allan G: Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues. Int J Pharm 1996, 141:17-25.
19. Goldschmidt H, Kligman AM: Exfoliative cytology of human horny layer, Methods of cell removal and microscopic techniques. Archs Derm 1967, 96:572.
20. Marks R, Dawber RPR: Skin surface biopsy: an improved technique for the examination of the horny layer. Br J Derm 1971, 84:117-123.
21. Marks R, Dykes PJ: Plasma and cutaneous drug levels after topical application of Piroxicam gel: a study in healthy volunteers. Skin Pharmacol 1994, 7:340-344.
22. Dykes PJ, Hill S, Marks R: Pharmacokinetics of topically applied metronidazol in two different formulations. Skin Pharmacol 1997, 10:28-33.
23. Pierard GE, Goffin V, Pierard-Franchimont C: Corneosurfametry: a predictive assessment of the interaction of personal-care cleansing products with human stratum corneum. Dermatology 1994, 189:2:152-156.
24. Zhai H, Maibach HI: Effect of barrier creams: human skin in vivo. Contact Dermatitis 1996, 35:2:92-96.
25. Robertson AR: The CIE 1976 color-difference formulae. Color Res Appl 1977, 2:7-11.
26. Piérard GE: EEMCO guidance for the assessment of skin color. J Eur Acad Dermatol 1997, 10:1-11.
27. Cross SE, Pugh WJ, Hadgraft J, Roberts MS: Probing the Effect of Vehicles on Topical Delivery: Understanding the Basic Relationship Between Solvent and Solute Penetration Using Silicone Membranes. Pharm Res 2001, 18:999-1005.
28. Twist JN, Zatz JL: Influence of solvents on paraben permeation through idealised skin model membranes. J Soc Cosm Chem 1986, 37:429-444.
29. Alberti I, Kalia YN, Naik A, Bonny JD, Guy RH: Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum in vivo. Int J Pharm 2001, 219:11-19.
30. Rosado C, Cross SE, Pugh WJ, Roberts MS, Hadgraft J: Effect of Vehicle Pre-Treatment on the Flux, Retention and Diffusion of Topically Applied Penetrants In Vitro. Pharm Res in press.
31. Tanojo H, Boelsma E, Junginger HE, Ponec M, Bodde H: In vivo human skin barrier modulation by topical application of fatty acids. Skin Pharmacol Appl Skin Physiol 1998, 11:87-97.
32. Rougier A, Lotte C, Maibach HI: In vivo relationship between percutaneous absorption and transepidermal water loss. In Percutaneous Absorption Edited by: Bronaugh RL, Maibach HI. New York: Marcel Dekker; 1989:175-190.
33. Davis AF, Gyurik RJ, Hadgraft J, Pellet MA, Walters KA: Formulation strategies for modulating skin permeation. In Dermatological and Transdermal Formulations Edited by: Walter KA. New York: Marcel Dekker; 2002:271-317.